Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary

Scynexis

11/08/2026 22:01

SCYNEXIS Inc SCYX.OQ reported quarterly adjusted earnings of 63 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.12.  The mean expectation of three analysts for the quarter was for a loss of 51 cents per share. Wall Street expected results to range from -56 cents to -40 cents per share.
Revenue fell 82.8% to $235.00 thousand from a year ago; analysts expected zero. 
SCYNEXIS Inc's reported EPS for the quarter was 63 cents​.
The company reported quarterly net income of $7.4 million.
SCYNEXIS Inc shares had risen by 26.7% this quarter and gained 1.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy" 
Wall Street's median 12-month price target for SCYNEXIS Inc is $32.00, about 83.9% above its last closing price of $5.16
This summary was machine generated from LSEG data August 11 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.51
0.63
Beat
Mar. 31 2026 
-0.99
-3.36
Missed
Dec. 31 2025 
1.01
1.94
Beat
Sep. 30 2025 
-1.60
-1.36
Beat